Colombo P - Search Results

1

Lung cancer: active therapeutic targeting and inhalational nanoproduct design.

Alhajj N, Chee CF, Wong TW, Rahman NA, Abu Kasim NH, Colombo P. Alhajj N, et al. Among authors: colombo p. Expert Opin Drug Deliv. 2018 Dec;15(12):1223-1247. doi: 10.1080/17425247.2018.1547280. Epub 2018 Nov 20. Expert Opin Drug Deliv. 2018. PMID: 30422017 Review.

2

Probing Critical Physical Properties of Lactose-Polyethylene Glycol Microparticles in Pulmonary Delivery of Chitosan Nanoparticles.

Alhajj N, Naharudin I, Colombo P, Quarta E, Wong TW. Alhajj N, et al. Among authors: colombo p. Pharmaceutics. 2021 Sep 29;13(10):1581. doi: 10.3390/pharmaceutics13101581. Pharmaceutics. 2021. PMID: 34683876 Free PMC article.

3

Design of multi-particulate "Dome matrix" with sustained-release melatonin and delayed-release caffeine for jet lag treatment.

Razali S, Bose A, Chong PW, Benetti C, Colombo P, Wong TW. Razali S, et al. Among authors: colombo p. Int J Pharm. 2020 Sep 25;587:119618. doi: 10.1016/j.ijpharm.2020.119618. Epub 2020 Jul 14. Int J Pharm. 2020. PMID: 32673769

4

Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design.

Quarta E, Sonvico F, Bettini R, De Luca C, Dotti A, Catalucci D, Iafisco M, Degli Esposti L, Colombo G, Trevisi G, Rekkas DM, Rossi A, Wong TW, Buttini F, Colombo P. Quarta E, et al. Among authors: colombo g, colombo p. Pharmaceutics. 2021 Nov 1;13(11):1825. doi: 10.3390/pharmaceutics13111825. Pharmaceutics. 2021. PMID: 34834240 Free PMC article.

5

Advanced Dome cellulose/alginate/chitosan composite matrix design with gastric and intestinal co-targeting capacities.

Razali S, Bose A, Benetti C, Chong PW, Miller M, Colombo P, Colombo G, Wong TW. Razali S, et al. Among authors: colombo g, colombo p. Int J Pharm. 2022 Nov 25;628:122226. doi: 10.1016/j.ijpharm.2022.122226. Epub 2022 Oct 1. Int J Pharm. 2022. PMID: 36191818

6

Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons.

Tulbah AS, Ong HX, Colombo P, Young PM, Traini D. Tulbah AS, et al. Among authors: colombo p. Expert Opin Drug Deliv. 2016 Oct;13(10):1407-20. doi: 10.1080/17425247.2016.1193150. Epub 2016 Jun 6. Expert Opin Drug Deliv. 2016. PMID: 27212150 Review.

7

Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management.

Marin L, Colombo P, Bebawy M, Young PM, Traini D. Marin L, et al. Among authors: colombo p. Expert Opin Drug Deliv. 2011 Sep;8(9):1205-20. doi: 10.1517/17425247.2011.588697. Epub 2011 May 26. Expert Opin Drug Deliv. 2011. PMID: 21615218 Review.

8

Controlled release dosage forms: from ground to space.

Colombo P, Bettini R, Peracchia MT, Santi P. Colombo P, et al. Eur J Drug Metab Pharmacokinet. 1996 Apr-Jun;21(2):87-91. doi: 10.1007/BF03190256. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8839681 Review.

9

Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies.

Marin L, Traini D, Bebawy M, Colombo P, Buttini F, Haghi M, Ong HX, Young P. Marin L, et al. Among authors: colombo p. Eur J Pharm Biopharm. 2013 Aug;84(3):566-72. doi: 10.1016/j.ejpb.2013.01.021. Epub 2013 Mar 7. Eur J Pharm Biopharm. 2013. PMID: 23474382

10

Dry powder formulation of simvastatin.

Tulbah AS, Ong HX, Morgan L, Colombo P, Young PM, Traini D. Tulbah AS, et al. Among authors: colombo p. Expert Opin Drug Deliv. 2015 Jun;12(6):857-68. doi: 10.1517/17425247.2015.963054. Epub 2014 Sep 22. Expert Opin Drug Deliv. 2015. PMID: 25244365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,303 results

Search Page